Last year, Pfizer joined the growing ranks of pharmaceutical firms with a digital strategy leader on their executive management teams. Lidia Fonseca, Pfizer’s first Chief Digital & Technology Officer, stepped into this role with a broad remit to set the company’s digital goals in drug discovery and development, operational processes and manufacturing, product sales, patient-facing experiences and more. No small task before COVID-19, the global pandemic has now forced companies to embrace digital tactics more than ever. Fonseca spoke with Asher Mullard about Pfizer’s pre-COVID-19 digital priorities, and how the pandemic has changed things.

中文翻译：

---

莉迪亚·丰塞卡（Lidia Fonseca）。

去年，辉瑞（Pfizer）在其执行管理团队中加入了数字策略领导者，从而加入了越来越多的制药公司行列。辉瑞公司的首位首席数字技术官Lidia Fonseca广泛担任这一职务，以设定公司在药物发现和开发，运营流程和制造，产品销售，面向患者的体验等方面的数字化目标。在COVID-19之前，这可不是一件容易的事，全球大流行现在迫使公司比以往任何时候都更喜欢采用数字策略。丰塞卡与Asher Mullard谈及了辉瑞公司在COVID-19之前的数字优先事项，以及该流行病如何改变了事情。